Vanguard Group »

Krystal Biotech shares owned by Vanguard Group

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $302M 2.4M 124.06
2023-09-30 $278M 2.4M 116.00
2023-06-30 $200M 1.7M 117.40
2023-03-31 $96M 1.2M 80.06
2022-12-31 $94M 1.2M 79.22
2022-06-30 $70M 1.1M 65.66
2022-03-31 $70M 1.1M 66.54
2021-09-30 $46M 889k 52.21
2021-06-30 $58M 846k 67.99
2021-03-31 $64M 830k 77.04
2020-12-31 $44M 739k 59.99
2020-09-30 $32M 733k 43.05
2020-06-30 $30M 725k 41.43
2020-03-31 $28M 638k 43.24
2019-12-31 $34M 615k 55.38
2019-09-30 $21M 595k 35.34
2019-03-31 $12M 354k 32.92
2018-12-31 $7.0M 337k 20.65
2018-09-30 $3.1M 174k 17.63
2018-06-30 $2.3M 153k 14.69
2018-03-31 $1.5M 149k 10.34
2017-12-31 $766k 74k 10.34